GREGORY D PERRY Insider Trading $SESN Sesen Bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GREGORY D PERRY.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GREGORY D PERRY. GREGORY D PERRY is See Remarks in QLT INC/BC ($QLTI) and Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and Director in Ocata Therapeutics, Inc. ($ACTC) and in Aegerion Pharmaceuticals, Inc. ($AEGR) and Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH).

GREGORY D PERRY in Sesen Bio, Inc.

Trading Symbol: SESN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY: Chief Financial and Business
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2015
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of GREGORY D PERRY in Sesen Bio, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AEGR, FNCH, KALA, NVLN, ACTC, SESN, TKTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 27 2015EBIOEleven Biotherapeu ...PERRY GREGORY DChief Financial and ...Option ExerciseA10.3957,500597,425203,248

Page:   1